Trial
NCT03387085
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Triple Negative Breast Cancer
Intervention
Aldoxorubicin HCl
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-09